VI
INDV icon

Vestcor Inc’s Indivior Pharmaceuticals INDV Stock Holding History

Vestcor Inc’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
34,263
+8,631
+34% +$313K 0.03% 439
2026
Q1 		$781K Buy
25,632
+14,561
+132% +$481K 0.02% 576
2025
Q4 		$397K Hold
11,071
– – 0.01% 779
2025
Q3 		$267K Buy
+11,071
New +$232K 0.01% 911

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's INDV Position: Q2 2026 in Review

Vestcor Inc increased its Indivior Pharmaceuticals (INDV) stake by 34% in Q2 2026, buying an estimated $313K and bringing the position to 34,263 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #439.

Vestcor Inc first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vestcor Inc held 34,263 shares of Indivior Pharmaceuticals worth $1.41M as of Q2 2026.
  • Vestcor Inc bought 8,631 Indivior Pharmaceuticals shares in Q2 2026, an estimated $313K.
  • Indivior Pharmaceuticals made up 0.03% of Vestcor Inc's portfolio in Q2 2026, its #439 holding.
  • Vestcor Inc first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.